Skip to main content Accessibility help
  • Print publication year: 2018
  • Online publication date: February 2018

21 - Oncofertility

from Section 3 - Infertility
1. Schover, LR Brey K, Lichtin A, Lipshultz LI, Jeha S. Oncologists’ attitudes and practices regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol 2002;20:1890–7.
2. Quinn, GP Vadaparampil ST, Lee JH et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol 2009;10:5952–7.
3. Letourneau, JM Melisko ME, Cedars MI, Rosen MP. A changing perspective: improving access to fertility preservation. Nat Rev Clin Oncol 2011;8:56–60.
4. Achille, MA, Rosberger Z, Robitaille R et al. Facilitators and obstacles to sperm banking in young men receiving gonadotoxic chemotherapy for cancer: the perspective of survivors and health care professionals. Human Reprod 2006:21;3206–16.
5. Loren, AW, Mangu, PB, Beck, LN et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:2500–2510 (ASCO Guidelines).
6. Murphy, SL, Xu, J, Kochanek, KD. Deaths: final data for 2013, Natl Vital Stat Rep. 201 6;64 ( 4 ):1–119.
7. American Cancer Society. Cancer facts and figures 2014;
8. Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975–2014, National Cancer Institute. Bethesda, MD,
9. Fertility Risk Tool;
10. Blumenfeld, Z, Avivi, I, Linn, S, Epelbaum, R, Ben-Shahar, M, Haim, N. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotropin-releasing hormone agonist in parallel to chemotherapy. Human Reprod 1996;11(8):1620–6.
11. Blatt, J, Poplack, DG, Sherrins, RJ. Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med 1981;304:1121–4.
12. Whitehead, E, Shalet, SM, Jones, PH Morris, Beardwell, CG, Deakin, DP. Gonadal function after combination chemotherapy for Hodgkin's disease in childhood. Arch Dis Child 1982;47:287–91.
13. Morita, Y, Perez, GI, Paris, F et al., Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphinosine-1-phosphate therapy, Nature Med October 2000:6(10):1109–14.
14. Glode, LM, Robinson, J, Gould, SF. Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone, Lancet 1981 May 23;1:1132–4.
15. Blumenfeld, Z, Wolff, M. von GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Human Reprod 2008;14 (6):541–2.
16. Blumenfeld, Z. Ovarian rescue/protection from chemotherapeutic agents. J Soc Gynecol Investig 2001:8(suppl 1):S60–4.
17. Fox, K, Scialla, H, Moore, H. Preventing chemotherapy-related amenorrhea using leuprolide during adjuvant therapy for early stage breast cancer. Proc Am Soc Clin Oncol 2001;21:98a.
18. Recchia, F, Sica, G, DeFillipis, S, Rosselli, M, Rea, S. Goserelin as an ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study, Anticancer Drugs 2002 Apr 13(4):417–24.
19. DelMastro, L, Cappi, M, Poggio, F et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev 2014 June 40(5):675–83.
20. Loibl, S, Gerber, B. Gonadotropin-releasing hormone analogue for premenopausal women with breast cancer. JAMA 2011;306(16):1760–1.
21. Elgindy, EA, El-Haieq, DO, Khoshid, OM et al. Gonadotropin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial. Obstet Gynecol 2013 Jan;121(1):78–86.
22. Vitek, WS, Shayne, M, Hoeger, K et al. Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis. Fertil Steril 2014;102:808–15.
23. Danforth, DR, Arboqast, LK, Friedman, CI. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil Steril 2005 May;83(5):1333–8.
24. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Practice Committee of American Society for Reproductive Medicine. Fertil Steril 2013 Nov;100(5):1214–23.
25. Lambertini, M, Mastro, L Del, Pescio, MC et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016 Jan 4;14:1.
26. Shrader, M, Muller, M, Sofikitis, N, Straub, B, Krause, H, Miller, K. “Onco-tese”: testicular sperm extraction in azospermic cancer patients before chemotherapy: new guidelines? Urology 2003 Feb:61(2);421–5.
27. Tesarick, J, Bahceci, M, Ozcan, C, Greco, E, Mendoza, C. Restoration of fertility by in-vitro spermatogenesis. Lancet 1999:353(9152):555–6.
28. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril 2013 Nov;100(5):1224–31.
29. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril 2014 May;101(5):1237–43.
30. In vitro maturation: a committee opinion. Fertil Steril 2013;99:663–6.
31. Noyes, N, Porcu, E, Borini, A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online 2009;18:277–85.
32. Acosta, JM, Tiao, G, Stein, JE, Mahour, GH. Temporary relocation of testes to the anterior abdominal wall before radiation therapy of the pelvis or perineum, J Pediatr Surg 2002 Aug;37(8):1232–3.
33. D'Angio, GJ, Exelby, PR, Ghavimi, F et al. Protection of certain structures from high doses of irradiation. Am J Roentgenol Radium Ther Nucl Med 1974;122(1):103–8.
34. Fallat, ME, Hutter, J. Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics 2008 May;121:e1461–9.
35. Bartholome, WG. Informed consent, parental permission, and assent in pediatric practice. Pediatrics 1995;96(5 pt. 1):981–2.
36. Partridge, AH, Gelber, S, Peppercorn, J et al. Web-based survey of fertility issues in young women with breast cancer, J Clin Oncol 2004 Oct 15;22(20):4174–83.
37. Lee, SJ, Schover, LR, Partridge, AH et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006 Jun 20;24(18):2917–31.
38. Azim, AA, Constantini-Ferrando, M, Oktay, K. Safety of fertility preservation by ovarian controlled stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 2008 Jun 1;26(16):2630–35.